Correction: Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma
Crossref DOI link: https://doi.org/10.1038/s41388-022-02534-0
Published Online: 2022-11-30
Published Print: 2023-01-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ruan, Hailong http://orcid.org/0000-0002-8126-6796
Li, Sen
Bao, Lin http://orcid.org/0000-0002-4390-9690
Zhang, Xiaoping http://orcid.org/0000-0003-0218-3288
Text and Data Mining valid from 2022-11-30
Version of Record valid from 2022-11-30
Article History
First Online: 30 November 2022